Rosiglitazone or pioglitazone in type 2 diabetes?
Reference:
de Vries, C. S. and Russell-Jones, D. L., 2009. Rosiglitazone or pioglitazone in type 2 diabetes? British Medical Journal, 339, b3076.
Related documents:
This repository does not currently have the full-text of this item.You may be able to access a copy if URLs are provided below. (Contact Author)
Official URL:
http://dx.doi.org/10.1136/bmj.b3076
Details
| Item Type | Articles |
| Creators | de Vries, C. S.and Russell-Jones, D. L. |
| DOI | 10.1136/bmj.b3076 |
| Uncontrolled Keywords | risk, cardiovascular death, congestive-heart-failure, mortality, thiazolidinedione use |
| Departments | Faculty of Science > Pharmacy & Pharmacology |
| Refereed | Yes |
| Status | Published |
| ID Code | 15803 |
Export
Actions (login required)
| View Item |
